An experimental study demonstrated that mice with osteoblast-specific deletion of PTHrP exhibited impaired recruitment and increased apoptosis of osteogenic cells resulting in decreased bone formation and premature osteoporosis [25], thus PTHrP would serve as an early and effective identifier of individuals at risk of developing low bone mass and osteoporosis. The gene discussed is PTHLH; the disease is osteoporosis.